You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

apalutamide

Showing 51 - 75 of 123
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)

Recruiting
  • Prostate Cancer
  • Apalutamide 60mg Tab
  • +5 more
  • Vancouver, British Columbia, Canada
  • +1 more
May 25, 2022

Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

Active, not recruiting
Has Results
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
Jan 17, 2023

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting
  • Neoadjuvant Therapy
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
  • +2 more
Feb 11, 2022

Castration-Resistant Prostatic Tumors Trial in Worldwide (Cetrelimab 480 mg, Apalutamide 240 mg)

Completed
  • Castration-Resistant Prostatic Neoplasms
  • Cetrelimab 480 mg
  • Apalutamide 240 mg
  • San Francisco, California
  • +33 more
Feb 24, 2022

Metastatic Castration-sensitive Prostate Cancer Trial in Osaka-sayama (Apalutamide)

Recruiting
  • Metastatic Castration-sensitive Prostate Cancer
  • Apalutamide
  • Ōsaka-sayama, Osaka, Japan
    Kindai University Hospital
Dec 6, 2020

Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)

Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
Nov 15, 2020

Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
Dec 23, 2020

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)

Active, not recruiting
  • Newly Diagnosed Oligometastatic Prostate Cancer
  • radical prostatectomy
  • +4 more
  • Long Beach, California
  • +2 more
Mar 16, 2022

Prostate Cancer Trial in New York (apalutamide, Everolimus)

Completed
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 29, 2021

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Apalutamide
  • +2 more
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))

Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
Aug 13, 2020

Healthy Trial in Merksem (Apalutamide)

Completed
  • Healthy
  • Apalutamide
  • Merksem, Belgium
    Clinical Pharmacology Unit
Aug 7, 2020

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Apalutamide
  • +3 more
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Apalutamide
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021

Prostate Cancer Trial in United States (ARN-509, Abiraterone, Leuprolide)

Active, not recruiting
  • Prostate Cancer
  • Baltimore, Maryland
  • +10 more
Feb 8, 2022

Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)

Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Tucson, Arizona
  • +145 more
Jan 17, 2023

Cancer of the Prostate Trial in Singapore (Apalutamide)

Completed
  • Cancer of the Prostate
  • Apalutamide
  • Singapore, Singapore
    Department of Urology
Mar 17, 2020

Prostatic Tumors Trial in Canada, United States (Niraparib, Apalutamide, Abiraterone Acetate)

Completed
  • Prostatic Neoplasms
  • West Hollywood, California
  • +5 more
Jul 16, 2020

Prostate Cancer Trial in Houston (Apalutamide, IHT)

Withdrawn
  • Prostate Cancer
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Feb 25, 2020

Prostate Cancer Trial in Boston (Leuprolide Acetate, Prednisone, Docetaxel)

Terminated
Has Results
  • Prostate Cancer
  • Leuprolide Acetate
  • +3 more
  • Boston, Massachusetts
  • +1 more
Apr 2, 2020

Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)

Recruiting
  • Prostate Cancer
  • +4 more
  • PET-directed Local Therapy using Surgery
  • +10 more
  • Long Beach, California
  • +15 more
Jul 29, 2022